Clinical trial
The Safety and Efficacy of the Buprenorphine Transdermal System (BTDS) in…
NCT00315445 · Purdue Pharma LP, Industry · Completed
Key facts
| NCT number | NCT00315445 |
|---|---|
| Title | The Safety and Efficacy of the Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Back Pain. |
| Official title | A Comparative Study of Buprenorphine TDS, Oxycodone/ Acetaminophen Tablets Qid and Placebo in Patients With Chronic Back Pain |
| Acronym | BP96-0604 |
| Lead sponsor | Purdue Pharma LP, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Back Pain |
| Intervention type | Drug |
| Interventions | Buprenorphine transdermal patch, Placebo oxycodone/acetaminophen tablets, OXY/APAP, Placebo transdermal patch (TDS) |
| Enrollment | 134 |
| Start date | Dec 1, 1997 |
| Primary completion | May 1, 1998 |
| Completion | May 1, 1998 |
| First posted | Apr 18, 2006 |
| Last update posted | Sep 3, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: